Tenosynovial Giant Cell Tumor Treatment Revolution: Vimseltinib's Edge Over Pexidartinib

Documenti analoghi

• Tenosynovial Giant Cell Tumor Treatment Revolution: Vimseltinib's Edge Over Pexidartinib
  di: Muhammad Affan Abid, et al.
  Pubblicazione: (2025-12-01)
• A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor
  di: Hairong Xu, et al.
  Pubblicazione: (2025-08-01)
• Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift
  di: Emanuela Palmerini, et al.
  Pubblicazione: (2024-08-01)
• Patient-Reported Continued Benefits in Patients Treated with Pexidartinib for Tenosynovial Giant Cell Tumor Based on a Real-World Study in the United States
  di: Margaret Wooddell PhD, MBA, et al.
  Pubblicazione: (2024-12-01)
• Overview of Pharmacological Therapies for Diffuse Tenosynovial Giant Cell Tumor
  di: Antonia Stamatiou, et al.
  Pubblicazione: (2023-12-01)